查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599256

兽医肿瘤学市场：治疗方法、动物类型、癌症类型分类 - 全球预测 2025-2030

Veterinary Oncology Market by Therapy (Chemotherapy, Immunotherapy, Radiology), Animal Type (Canine, Feline), Cancer Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年兽医肿瘤市场规模为3.903亿美元，预计2024年将达到4.2972亿美元，复合年增长率为10.24%，预计到2030年将达到7.7277亿美元。

兽医肿瘤学市场是一个利基但快速发展的领域，专注于动物癌症的诊断和治疗。由于宠物癌症盛行率不断上升，这一领域正在成为兽医护理的一个重要方面，特别是在宠物拥有率和动物保健支出较高的发达地区。对兽医肿瘤学的需求源于宠物饲主对延长宠物生活品质和寿命的情感和经济价值，从而推动了对先进治疗和诊断的需求。兽医肿瘤学的治疗应用包括化疗、放射线治疗、免疫治疗和手术干预，最终用途包括兽医医院、诊所和专门的兽医癌症治疗中心。

主要市场统计
基准年[2023] 3.903 亿美元
预测年份 [2024] 4.2972 亿美元
预测年份 [2030] 77277万美元
复合年增长率（%） 10.24%

兽医诊断技术的持续进步、宠物癌症发病率的上升以及饲主对可用治疗方案的认识不断提高，对市场成长产生了重大影响。动物用药品和生技药品的创新在透过标靶治疗和个人化医疗方法来增强治疗通讯协定方面发挥关键作用。最有前景的机会之一在于开发更实惠、更容易获得的治疗方案，以及整合人工智慧和机器学习技术以实现早期检测和更好的预后工具。然而，高昂的治疗费用、有限的保险范围以及宠物饲主的情感负担等挑战可能会阻碍市场的扩张。

此外，兽医肿瘤学基础设施的地理限制以及对更专业的兽医肿瘤学家的需求凸显了潜在的障碍。为了利用成长机会，公司应专注于旨在降低成本、更有效的治疗替代方案的倡议，并寻求与高科技公司建立合作伙伴关係以增强诊断能力。值得探索生物技术和基因组研究等创新领域，以开发更精确、更有效的治疗方法。兽医肿瘤市场的高度专业化和快速增长的性质需要不断适应技术进步和不断变化的消费者期望，以维持业务成长。

市场动态：揭示快速发展的兽医肿瘤学市场的关键市场洞察

供需的动态交互作用正在改变兽医肿瘤学市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 宠物癌症盛行率增加
    • 不断增加的癌症管理研究和开发倡议
    • 宠物治疗的技术进步
  • 市场限制因素
    • 宠物癌症治疗费用高昂
  • 市场机会
    • 人们对兽医癌症治疗的认识不断增强
    • 政府积极努力
  • 市场挑战
    • 用于治疗宠物癌症的药物的副作用

波特五力：驾驭兽医肿瘤​​学市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解兽医肿瘤市场的外部影响

外部宏观环境因素在塑造兽医肿瘤学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解兽医肿瘤学市场的竞争格局

兽医肿瘤学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵兽医肿瘤学市场供应商的绩效评估

FPNV定位矩阵是评估兽医肿瘤学市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了兽医肿瘤学市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对兽医肿瘤学市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 宠物癌症发生率增加
      • 扩大癌症治疗的研究和开发工作
      • 宠物治疗的技术进步
    • 抑制因素
      • 宠物癌症治疗费用高昂
    • 机会
      • 人们对兽医癌症治疗的认识不断增强
      • 有利的政府倡议
    • 任务
      • 用于治疗宠物癌症的药物的副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章兽医肿瘤市场治疗

  • 化疗
  • 免疫疗法
  • 放射科
  • 外科手术

第七章依动物类型分類的兽医肿瘤学市场

  • 狗
  • 猫科动物

第八章按癌症类型分類的兽医肿瘤学市场

  • 淋巴瘤
  • 乳癌和鳞状细胞癌
  • 肥大细胞癌

第九章美洲兽医肿瘤市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太兽医肿瘤市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲兽医肿瘤市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AB Science SA
  • Anivive Lifesciences
  • Ardent Animal Health, LLC
  • CH Boehringer Sohn AG & Ko. KG
  • Ceva Sante Animale SA
  • Covetrus, Inc.
  • Elanco Animal Health Incorporated
  • ELIAS Animal Health
  • Fidocure
  • IDEXX Laboratories, Inc.
  • Karyopharm Therapeutics Inc.
  • Leroy Biotech SAS
  • Morphogenesis, Inc.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • PetCure Oncology LLC
  • PharmAust Limited
  • Regeneus Ltd.
  • Rhizen Pharmaceuticals AG
  • Torigen Pharmaceuticals Inc.
  • Varian Medical Systems, Inc.
  • Vetco Pharmaceuticals Inc.
  • VetDC, Inc.
  • Vetoquinol SA
  • Virbac SA
  • VolitionRx Limited
  • Zoetis Inc.
Product Code: MRR-A339DAEF9FFF

The Veterinary Oncology Market was valued at USD 390.30 million in 2023, expected to reach USD 429.72 million in 2024, and is projected to grow at a CAGR of 10.24%, to USD 772.77 million by 2030.

The veterinary oncology market is a niche but rapidly evolving segment, focusing on the diagnosis and treatment of cancer in animals. This field is increasingly becoming a critical aspect of veterinary care due to the rising prevalence of cancer among pets, notably in developed regions where pet ownership and animal healthcare spending are high. The necessity of veterinary oncology lies in the emotional and financial value pet owners place on extending the quality and longevity of their pets' lives, fueling demand for advanced treatments and diagnostics. Applications of veterinary oncology include chemotherapy, radiation therapy, immunotherapy, and surgical interventions, with numerous end-use scope extending to veterinary clinics, hospitals, and specialized cancer treatment centers for animals.

KEY MARKET STATISTICS
Base Year [2023] USD 390.30 million
Estimated Year [2024] USD 429.72 million
Forecast Year [2030] USD 772.77 million
CAGR (%) 10.24%

Market growth is significantly influenced by the continuous advancements in veterinary diagnostics, the rising incidence of pet cancer, and the increasing awareness among pet owners about available treatment options. Innovations in veterinary pharmaceuticals and biologics play a crucial role, with targeted therapies and personalized medical approaches paving the way for enhanced treatment protocols. One of the most promising opportunities lies in the development of more affordable and accessible treatment options, as well as the integration of AI and machine learning technologies for early detection and better prognostic tools. However, challenges such as the high cost of treatments, limited insurance coverage, and the emotional burden on pet owners can impede market expansion.

Furthermore, geographical limitations in veterinary oncology infrastructure and the need for more specialized veterinary oncologists underscore potential barriers. To leverage growth opportunities, businesses should focus on R&D initiatives aimed at low-cost, high-efficacy treatment alternatives and explore partnerships with tech companies to enhance diagnostic capabilities. Innovation areas worth exploring include biotechnological advancements and genomic studies to develop more precise and effective therapies. The nature of the veterinary oncology market is highly specialized and rapidly growing, demanding continuous adaptation to technological advancements and changing consumer expectations to sustain business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Oncology Market

The Veterinary Oncology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Prevalence of Cancer in Pet Animals
    • Growing R&D Initiatives for Cancer Management
    • Technological Advancement in Pet Treatment
  • Market Restraints
    • High Cost of Pet Cancer Treatment
  • Market Opportunities
    • Rising Awareness Regarding Veterinary Cancer Therapies
    • Favourable Government Initiatives
  • Market Challenges
    • Adverse Effect of Drugs used for Pet Cancer Treatment

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Oncology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Oncology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Oncology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Oncology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Oncology Market

A detailed market share analysis in the Veterinary Oncology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Oncology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Oncology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Oncology Market

A strategic analysis of the Veterinary Oncology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Oncology Market, highlighting leading vendors and their innovative profiles. These include AB Science SA, Anivive Lifesciences, Ardent Animal Health, LLC, C.H. Boehringer Sohn AG & Ko. KG, Ceva Sante Animale S.A., Covetrus, Inc., Elanco Animal Health Incorporated, ELIAS Animal Health, Fidocure, IDEXX Laboratories, Inc., Karyopharm Therapeutics Inc., Leroy Biotech S.A.S., Morphogenesis, Inc., Nippon Zenyaku Kogyo Co., Ltd., PetCure Oncology LLC, PharmAust Limited, Regeneus Ltd., Rhizen Pharmaceuticals AG, Torigen Pharmaceuticals Inc., Varian Medical Systems, Inc., Vetco Pharmaceuticals Inc., VetDC, Inc., Vetoquinol S.A., Virbac SA, VolitionRx Limited, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Oncology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Therapy, market is studied across Chemotherapy, Immunotherapy, Radiology, and Surgery.
  • Based on Animal Type, market is studied across Canine and Feline.
  • Based on Cancer Type, market is studied across Lymphoma, Mammary and Squamous Cell Cancer, and Mast Cell Cancer.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Cancer in Pet Animals
      • 5.1.1.2. Growing R&D Initiatives for Cancer Management
      • 5.1.1.3. Technological Advancement in Pet Treatment
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Pet Cancer Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising Awareness Regarding Veterinary Cancer Therapies
      • 5.1.3.2. Favourable Government Initiatives
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse Effect of Drugs used for Pet Cancer Treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Oncology Market, by Therapy

  • 6.1. Introduction
  • 6.2. Chemotherapy
  • 6.3. Immunotherapy
  • 6.4. Radiology
  • 6.5. Surgery

7. Veterinary Oncology Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Canine
  • 7.3. Feline

8. Veterinary Oncology Market, by Cancer Type

  • 8.1. Introduction
  • 8.2. Lymphoma
  • 8.3. Mammary and Squamous Cell Cancer
  • 8.4. Mast Cell Cancer

9. Americas Veterinary Oncology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Veterinary Oncology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary Oncology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AB Science SA
  • 2. Anivive Lifesciences
  • 3. Ardent Animal Health, LLC
  • 4. C.H. Boehringer Sohn AG & Ko. KG
  • 5. Ceva Sante Animale S.A.
  • 6. Covetrus, Inc.
  • 7. Elanco Animal Health Incorporated
  • 8. ELIAS Animal Health
  • 9. Fidocure
  • 10. IDEXX Laboratories, Inc.
  • 11. Karyopharm Therapeutics Inc.
  • 12. Leroy Biotech S.A.S.
  • 13. Morphogenesis, Inc.
  • 14. Nippon Zenyaku Kogyo Co., Ltd.
  • 15. PetCure Oncology LLC
  • 16. PharmAust Limited
  • 17. Regeneus Ltd.
  • 18. Rhizen Pharmaceuticals AG
  • 19. Torigen Pharmaceuticals Inc.
  • 20. Varian Medical Systems, Inc.
  • 21. Vetco Pharmaceuticals Inc.
  • 22. VetDC, Inc.
  • 23. Vetoquinol S.A.
  • 24. Virbac SA
  • 25. VolitionRx Limited
  • 26. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY ONCOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY ONCOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY ONCOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY ONCOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY AND SQUAMOUS CELL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023